AGATHA GIANNESE: Open Payments
NPI 1689391039 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,755 in 70 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,755
Food & beverage: $1,556Education: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $526 |
| Regeneron Healthcare Solutions, Inc. | 8 | $390 |
| ABBVIE INC. | 22 | $267 |
| UCB, Inc. | 9 | $229 |
| GENZYME CORPORATION | 3 | $99 |
| Galderma Laboratories, L.P. | 2 | $64 |
| LNHC, Inc | 2 | $34 |
| Lilly USA, LLC | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Cipher Pharmaceuticals US LLC | 1 | $24 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, RINVOQ, LIBTAYO, ZELSUVMI, TALTZ.
Industry payments across IL — which companies pay providers there.
